GlassScriptPhysician profile
Robert J Seiler
NPI 1831159847
$35,240.35
in general payments reported to CMS, 2019-2025
48 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,075 · 2020: $389 · 2021: $1,876 · 2022: $16K · 2023: $14K · 2024: $636 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,531 · Honoraria: $5,950 · Food and Beverage: $2,113 · Travel and Lodging: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,531.25 |
| Honoraria | $5,950.00 |
| Food and Beverage | $2,113.31 |
| Travel and Lodging | $149.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18,830.56 | 2022-2025 | Nexplanon, Nuvaring |
| Myriad Women'S Health, INC. | $6,125.91 | 2023 | Myrisk |
| Myriad Genetic Laboratories, INC. | $2,800.00 | 2022 | |
| Merck Sharp & Dohme LLC | $2,591.90 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Hologic Sales and Service, LLC | $656.58 | 2019-2025 | Acessa Provu System, Coolseal Generator, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $420.83 | 2021-2024 | Ova1 |
| Abbvie INC. | $366.18 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $277.57 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $254.34 | 2022 | |
| Ethicon US, LLC | $250.38 | 2020-2023 | Stratafix |
| Heron Therapeutics, INC. | $219.35 | 2023-2025 | Zynrelef |
| Baxter Healthcare | $172.34 | 2020-2021 | |
| Lupin INC. | $160.26 | 2019-2020 | |
| Medicem INC. | $144.20 | 2022-2023 | |
| Biogen, INC. | $136.78 | 2024-2025 | Zurzuvae |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Seiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.